Peptide-pulsed Dendritic Cells Induce Antigen-specific CTL-mediated Protective Tumor Immunity

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1996 Jan 1

PMID 8551233

Citations 122

Authors

C M Celluzzi

J I Mayordomo

W J Storkus

M T Lotze

L D Falo Jr

Affiliations

Soon will be listed here.

Abstract

Cytotoxic T lymphocytes (CTLs) are a critical component of the immune response to tumors. Tumor-derived peptide antigens targeted by CTLs are being defined for several human tumors and are potential immunogens for the induction of specific antitumor immunity. Dendritic cells (DC) are potent antigen-presenting cells (APCs) capable of priming CTL responses in vivo. Here we show that major histocompatibility complex class I-presented peptide antigen pulsed onto dendritic APCs induces protective immunity to lethal challenge by a tumor transfected with the antigen gene. The immunity is antigen specific, requiring expression of the antigen gene by the tumor target, and is eliminated by in vivo depletion of CD8+ T cells. Furthermore, mice that have rejected the transfected tumor are protected from subsequent challenge with the untransfected parent tumor. These results suggest that immunization strategies using antigen-pulsed DC may be useful for inducing tumor-specific immune responses.

Citing Articles

MHC class I trafficking signal improves induction of cytotoxic T lymphocyte using artificial antigen presenting cells.

Sasaki K, Murata K, Minowa T, Shijubou N, Kobayashi H, Nakatsugawa M Biochem Biophys Rep. 2025; 41:101946.

PMID: 40046256 PMC: 11880709. DOI: 10.1016/j.bbrep.2025.101946.

Depletion of slow-cycling PDGFRαADAM12 mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.

Di Carlo S, Raffenne J, Varet H, Ode A, Cabrerizo Granados D, Stein M Nat Immunol. 2023; 24(11):1867-1878.

PMID: 37798557 PMC: 10602852. DOI: 10.1038/s41590-023-01642-7.

A novel CTLA-4 blocking strategy based on nanobody enhances the activity of dendritic cell vaccine-stimulated antitumor cytotoxic T lymphocytes.

Yang W, Pang Y, Wang X, Lai Z, Lu Y, Zheng S Cell Death Dis. 2023; 14(7):406.

PMID: 37419930 PMC: 10328924. DOI: 10.1038/s41419-023-05914-w.

Melanoma stem cell vaccine induces effective tumor immunity against melanoma.

Yin Q, Zhao N, Chang Y, Dong M, Xu M, Xu W Hum Vaccin Immunother. 2023; 19(1):2158670.

PMID: 37067182 PMC: 10114997. DOI: 10.1080/21645515.2022.2158670.

Migration of stem-like CD8 T cells between tissue microenvironments underpins successful anti-tumour immune responses.

Kennedy B, Dean I, Withers D Discov Immunol. 2023; 2(1):kyad004.

PMID: 37008996 PMC: 10052398. DOI: 10.1093/discim/kyad004.

References

Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K . Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer. 1990; 66(9):2012-6. DOI: 10.1002/1097-0142(19901101)66:9<2012::aid-cncr2820660928>3.0.co;2-n. View

Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S . Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992; 176(6):1693-702. PMC: 2119469. DOI: 10.1084/jem.176.6.1693. View

Benjamin R, Madrigal J, Parham P . Peptide binding to empty HLA-B27 molecules of viable human cells. Nature. 1991; 351(6321):74-7. DOI: 10.1038/351074a0. View

Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H . Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991; 351(6324):290-6. DOI: 10.1038/351290a0. View

Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H . Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol. 1994; 24(3):605-10. DOI: 10.1002/eji.1830240317. View

Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, HANCE A, Soler P . Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest. 1993; 91(2):566-76. PMC: 287979. DOI: 10.1172/JCI116236. View

Rock K, Fleischacker C, GAMBLE S . Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant. J Immunol. 1993; 150(4):1244-52. View

Murphy G, Radu A, Kaminer M, Berd D . Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy. J Invest Dermatol. 1993; 100(3):335S-341S. DOI: 10.1111/1523-1747.ep12470236. View

Townsend A, Trowsdale J . The transporters associated with antigen presentation. Semin Cell Biol. 1993; 4(1):53-61. DOI: 10.1006/scel.1993.1007. View

10.

Inaba K, Metlay J, Crowley M, Steinman R . Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol. 1990; 6(2-3):197-206. DOI: 10.3109/08830189009056630. View

11.

Becker Y . Dendritic cell activity against primary tumors: an overview. In Vivo. 1993; 7(3):187-91. View

12.

Steinman R, Inaba K . Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv Exp Med Biol. 1993; 329:1-9. DOI: 10.1007/978-1-4615-2930-9_1. View

13.

Chen L, Linsley P, Hellstrom K . Costimulation of T cells for tumor immunity. Immunol Today. 1993; 14(10):483-6. DOI: 10.1016/0167-5699(93)90262-J. View

14.

Doherty P, Knowles B, Wettstein P . Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. Adv Cancer Res. 1984; 42:1-65. DOI: 10.1016/s0065-230x(08)60455-8. View

15.

Bastin J, Rothbard J, Davey J, Jones I, Townsend A . Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med. 1987; 165(6):1508-23. PMC: 2188365. DOI: 10.1084/jem.165.6.1508. View

16.

Inaba K, Young J, Steinman R . Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. J Exp Med. 1987; 166(1):182-94. PMC: 2188638. DOI: 10.1084/jem.166.1.182. View

17.

Azizi E, Bucana C, Goldberg L, Kripke M . Perturbation of epidermal Langerhans cells in basal cell carcinomas. Am J Dermatopathol. 1987; 9(6):465-73. DOI: 10.1097/00000372-198712000-00001. View

18.

Auchincloss Jr H, Ghobrial R, Russell P, Winn H . Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation. 1988; 45(6):1118-23. DOI: 10.1097/00007890-198806000-00024. View

19.

Moore M, Carbone F, Bevan M . Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 1988; 54(6):777-85. DOI: 10.1016/s0092-8674(88)91043-4. View

20.

Rosenberg S, Packard B, Aebersold P, Solomon D, Topalian S, TOY S . Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med. 1988; 319(25):1676-80. DOI: 10.1056/NEJM198812223192527. View